The department of pathology operates several research cores for the Brigham Reseach institute, Dana Farber/Harvard Cancer Center, and Partners HealthCare.
The Specialized Histopathology (SHP) Core provides consultative and interpretive pathology services including high quality, timely, state-of-the-art analysis of tissues obtained from a variety of experimental systems, including rodents, fish, and monkeys. This Core also provides professional expertise to assist in experimental design and the development and interpretation
of tests and their results.
The Tissue Microarray (TMA) Core generates tissue microarrays that allow hundreds of tumors and samples to be evaluated on a single slide, maximizing precious tissue resources. The Core also provides access to TMA Profiler, a Web-based database that facilitates data dissemination and sharing.
The Cytogenetics Core provides insight into regions of the genome that are pathogenetic in various neoplasms, leading to an understanding of the molecular pathways that play a role in the biology of cancer. The Cytogenetics Core provides conventional metaphase karyotyping and a comprehensive menu of molecular cytogenetic methods.
The Circulating Tumor Cell Core Facility uses immunomagnetic technology developed by Veridex/Janssen Diagnostics, LLC (Raritan, NJ) to isolate rare tumor cells from whole blood. Isolated tumor cells can then be counted or used for downstream analysis such as molecular studies or flow cytometry.
This page was last modified on 11/13/2015